BridgeBio Oncology Therapeutics, Inc. (BBOT) earnings date, market-implied expected move, and options open interest by expiry

earnings room

4.72−1.05%

Next report

fiscal Q3 2026

Nov 13

after close · estimated date

days out

Intraday

−2.68% since 9 AM

High 4.85 at 9:30 am ET, low 4.72 at 3:45 pm ET.

Revenue flow

not on file

No filed income statement on record yet. These are the standardized lines of a company’s own filing, so a company that has not reported one has nothing to show here.

Expected move

No options chain priced for this ticker yet.

Linked exposure

placeholder

No linked names measured for this ticker yet.

Positioning

placeholder

No options positioning captured for this ticker yet.

Earnings history

implied in pale · realized in full ink

Q2 FY26—

+2.39%—

3-quarter memory

Event sensitivity

release-day history · not a forecast

NFPjobs report2.1×up 5 of 9±4.1% vs ±1.9% · 9
CPIconsumer prices2.0×up 4 of 9±3.8% vs ±1.9% · 9
PPIproducer prices2.0×up 3 of 9±3.8% vs ±1.9% · 9
PCEpersonal income & outlays1.5×up 7 of 17±2.8% vs ±1.9% · 17
FOMCrate decision1.2×up 5 of 18±2.3% vs ±1.9% · 18
CPROFcorporate profits1.1×up 5 of 10±2.0% vs ±1.9% · 10
GDPgross domestic product0.9×up 7 of 16±1.8% vs ±1.9% · 16

Past release days against BBOT’s ordinary ±1.9% day, from our own stored closes. History, not a forecast; kinds with fewer than six releases are omitted.

Track BBOT

Watchlist prices, news filtered to it, and its next report on your desk.

Market-implied ranges describe what current option prices imply, never a forecast. Prices via Intrinio.